SCHEMBL26328503

SCHEMBL26328503

CCO[C@H](COC(=O)OC(C)C)[C@@H](OC(=O)CCCCCCC(=O)O)[C@@H](O)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26404967 0.93 RIPK1 (0.30) —
SCHEMBL26317626 0.90 — —
SCHEMBL26325804 0.73 FAP (0.31) —
SCHEMBL26325762 0.72 — —
SCHEMBL26325789 0.72 — —
SCHEMBL26325783 0.70 — —
SCHEMBL26325771 0.69 — —
SCHEMBL26316679 0.69 RIPK1 (0.31) —
SCHEMBL26317120 0.69 RIPK1 (0.31) —
SCHEMBL27284023 0.67 RIPK1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279014-A1 COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS GILEAD SCIENCES, INC. 2023-09-07 — — US disclosed
Send feedback